|
|||||
|
|

Personal care and home fragrance retailer Bath & Body Works (NYSE:BBWI) missed Wall Street’s revenue expectations in Q3 CY2025, with sales flat year on year at $1.59 billion. Its GAAP profit of $0.37 per share was 5.1% below analysts’ consensus estimates.
Is now the time to buy BBWI? Find out in our full research report (it’s free for active Edge members).
Bath & Body Works faced a challenging Q3 as it missed Wall Street’s revenue and profit expectations, with management openly acknowledging that recent strategies failed to drive durable growth. CEO Daniel Heaf described the results as “not living up to the expectations we all have for this brand,” attributing underperformance to an overemphasis on adjacent categories and increased reliance on promotions that diluted brand equity. The company saw declines across all core categories, and management admitted that efforts to attract new consumers have not delivered the desired growth. Heaf emphasized, “We have not attracted a younger consumer,” and said the business has become “slow and inefficient,” requiring a comprehensive strategic reset.
Looking ahead, Bath & Body Works is pivoting to focus investment in its core categories—body care, home fragrance, and soaps—while simplifying assortments and exiting low-performing segments like hair and men’s grooming. Management expects that new product launches, digital enhancements, and the launch on Amazon will begin to show results by late 2026, though growth is not anticipated for the full year. CFO Eva Boratto cautioned, “We don’t expect it to impact the business in any meaningful way until the second half of the year,” and noted that cost savings initiatives will be reinvested to support product and brand innovation.
Management attributed the quarter’s performance to a combination of weak demand in core categories, elevated promotional activity, and delayed benefits from ongoing transformation efforts.
Management expects 2026 to be a year of investment and transition, with product innovation, digital expansion, and cost optimization as main themes.
In the coming quarters, our team will closely monitor (1) the pace and effectiveness of new product launches in core categories, (2) progress in digital channel penetration, including the Amazon rollout, and (3) the realization of planned cost savings and reinvestment in brand initiatives. Execution on these fronts will be key to Bath & Body Works’ turnaround.
Bath and Body Works currently trades at $15.81, down from $21.04 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| 12 hours | |
| Dec-10 | |
| Dec-08 | |
| Dec-08 | |
| Dec-08 | |
| Dec-07 | |
| Dec-04 | |
| Dec-02 | |
| Dec-01 | |
| Dec-01 | |
| Dec-01 | |
| Nov-30 | |
| Nov-29 | |
| Nov-25 |
Bath & Body Works Bets on Aspiration, Influencers and Train-Station Scent Diffusers
BBWI
The Wall Street Journal
|
| Nov-25 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite